Floatz logo

Human Placental Derived Stem Cell

Krabbe's Disease

New York Medical CollegeCell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Krabbe's Disease cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BB
Anti-Thymoglobulin, Rabbit
Masonic Cancer Center, University of Minnesota
Phase 2/3B
Evomela
Masonic Cancer Center, University of Minnesota
Phase 2B
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 12 →

Same molecule, other indications

Human Placental Derived Stem Cell is also rated in:

mucopolysaccharidosis type 6Dormant
CC
Indicative ·
47 / 100
View asset →
adrenoleukodystrophyDormant
CC
Indicative ·
47 / 100
View asset →
mucopolysaccharidosis type 1Dormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →